Delivery Order SPE2DE24D0013-SPE2D625F7NK8
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. (Sunnyvale, CA) on April 23, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of April 30, 2025, and involves no set-aside provisions. This delivery order represents procurement activity under Cepheid's existing indefinite...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 14, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, which is due for completion by July 21, 2025, utilizes no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a continuation of Cepheid's established role as...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,907.58 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, involves molecular diagnostic testing solutions, specifically reagents and assays for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The work will be performed in Sunnyvale, California, and no small business set-aside designation was...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F7NK8Delivery Order
The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects Cepheid's established role as a primary supplier of molecular diagnostic technologies and test kits to federal healthcare systems. Cepheid, a for-profit manufacturer specializing in advanced diagnostic systems and molecular testing solutions, holds substantial existing federal contracts with the Department of Veterans Affairs and Defense Logistics Agency. The company maintains two significant Indefinite Delivery Vehicle contracts with VA Veterans Integrated Service Networks valued at over $35 million combined, which provide molecular diagnostic testing reagents, assays, and PCR testing services. This delivery order aligns with Cepheid's broader mission of supplying diagnostic equipment and reagents for detecting infectious diseases across federal healthcare networks, particularly for high-demand respiratory pathogens and emerging infectious disease threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/18/25 |